Biochemical markers of liver fibrosis in HCV patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Laminin and syndecan-1 levels as biomarkers in patients with hepatitis C

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

significance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma

Serum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma